The Lancet, ISSN 0140-6736, 04/2018, Volume 391, Issue 10130, pp. 1589 - 1598
There is a need to increase access to surgical treatments in African countries, but perioperative complications represent a major global health-care burden....
MORTALITY | SURGERY | STATEMENT | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | DISEASES | RESCUE | GLOBAL HEALTH | INCOME COUNTRIES | FAILURE | CARE | Medical personnel | Low income groups | Surgical outcomes | Medical research | Risk groups | Complications | Mortality | Critical care | Patients | Clinical outcomes | Studies | Hospitals | Risk assessment | Surgery | Population | Public health
MORTALITY | SURGERY | STATEMENT | MEDICINE, GENERAL & INTERNAL | COST-EFFECTIVENESS | DISEASES | RESCUE | GLOBAL HEALTH | INCOME COUNTRIES | FAILURE | CARE | Medical personnel | Low income groups | Surgical outcomes | Medical research | Risk groups | Complications | Mortality | Critical care | Patients | Clinical outcomes | Studies | Hospitals | Risk assessment | Surgery | Population | Public health
Journal Article
The Lancet Global Health, ISSN 2214-109X, 04/2019, Volume 7, Issue 4, pp. e513 - e522
Maternal and neonatal mortality is high in Africa, but few large, prospective studies have been done to investigate the risk factors associated with these poor...
MORTALITY | STATEMENT | MIDDLE-INCOME COUNTRIES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MISS | HEALTH | DEATHS | PATIENT OUTCOMES
MORTALITY | STATEMENT | MIDDLE-INCOME COUNTRIES | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MISS | HEALTH | DEATHS | PATIENT OUTCOMES
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At...
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article